Novo Nordisk and Hims & Hers Health have reportedly ended their legal feud and are preparing a new partnership to sell Novo's ...

March 6 (Reuters) - Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health platform, bringing an ...

Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.

Novo Nordisk has sued Hims & Hers for patent infringement, saying the online site is selling cheaper, unapproved copies of the Wegovy weight loss drug ...

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy.

Novo's lawsuit comes less than one week after Hims & Hers announced plans to sell a compounded version of Novo's weight-loss pill Wegovy.

Pharmaceutical giant Novo Nordisk announced Monday it is suing telemedicine platform Hims & Hers for allegedly “deceiving patients and putting their health at risk” by selling compounded versions of ...

Add Yahoo as a preferred source to see more of our stories on Google. Novo Nordisk files suit against telehealth provider Hims & Hers, alleging unauthorized versions of Ozempic and Wegovy. The case ...

Novo Nordisk (NVO) stock is in focus as Strive Pharmacy, a pharmacy partner for Hims & Hers (HIMS) plans to offer a compounded version of Wegovy pill. Read more here.

March 6 () - Wegovy maker Novo ‌Nordisk plans to ‌sell its weight-loss drugs ​on Hims & Hers Health platform, bringing an end ...

Pharmaceutical giant Novo Nordisk announced Monday it is suing telemedicine platform Hims & Hers for allegedly “deceiving patients and putting their health at risk” by selling compounded versions of ...